Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CITED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANKRD35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XKR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPLL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NECTIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MXD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on